Page last updated: 2024-10-26

9-(2-hydroxy-3-nonyl)adenine and Chronic Illness

9-(2-hydroxy-3-nonyl)adenine has been researched along with Chronic Illness in 1 studies

9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase

Research Excerpts

ExcerptRelevanceReference
"Colitis was associated with decreased food intake and body weight, augmented spleen weight, and increased levels of colonic TNF-α, IL-6, and MDA."1.36The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors. ( Antonioli, L; Awwad, O; Blandizzi, C; Colucci, R; Da Settimo, F; Duranti, E; Fornai, M; Ghisu, N; La Motta, C; Natale, G; Tuccori, M; Virdis, A, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonioli, L1
Fornai, M1
Colucci, R1
Awwad, O1
Ghisu, N1
Tuccori, M1
Da Settimo, F1
La Motta, C1
Natale, G1
Duranti, E1
Virdis, A1
Blandizzi, C1

Other Studies

1 other study available for 9-(2-hydroxy-3-nonyl)adenine and Chronic Illness

ArticleYear
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:2

    Topics: Adenine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Blotting, Western; Body Weigh

2010